TADALAFIL
5 mg/1 · Tablet
By Asclemed USA, Inc.
- NDC
- 76420-546
- Route
- Oral
- Therapeutic class
- Phosphodiesterase 5 Inhibitor , Phosphodiesterase 5 Inhibitors [MoA]
- Marketing category
- ANDA
Package sizes
- 30 TABLET in 1 BOTTLE (76420-546-30)NDC 76420-546-30Available to order
- 60 TABLET in 1 BOTTLE (76420-546-60)NDC 76420-546-60Available to order
- 90 TABLET in 1 BOTTLE (76420-546-90)NDC 76420-546-90Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
%22%2F%3E%0A%3Cg%20transform%3D%22translate(240%20166)%22%3E%0A%20%20%20%20%3Cdefs%3E%0A%20%20%20%20%20%20%3ClinearGradient%20id%3D%22reconBody%22%20x1%3D%220%22%20y1%3D%220%22%20x2%3D%221%22%20y2%3D%220%22%3E%0A%20%20%20%20%20%20%20%20%3Cstop%20offset%3D%220%22%20stop-color%3D%22%237c3aed%22%20stop-opacity%3D%220.5%22%2F%3E%0A%20%20%20%20%20%20%20%20%3Cstop%20offset%3D%220.55%22%20stop-color%3D%22%237c3aed%22%20stop-opacity%3D%220.85%22%2F%3E%0A%20%20%20%20%20%20%20%20%3Cstop%20offset%3D%221%22%20stop-color%3D%22%237c3aed%22%20stop-opacity%3D%220.5%22%2F%3E%0A%20%20%20%20%20%20%3C%2FlinearGradient%3E%0A%20%20%20%20%3C%2Fdefs%3E%0A%20%20%20%20%3Cg%20transform%3D%22translate(0%204)%22%3E%0A%20%20%20%20%20%20%3Crect%20x%3D%22-28%22%20y%3D%22-72%22%20width%3D%2256%22%20height%3D%2214%22%20rx%3D%223%22%20fill%3D%22%23312065%22%20opacity%3D%220.65%22%2F%3E%0A%20%20%20%20%20%20%3Crect%20x%3D%22-22%22%20y%3D%22-58%22%20width%3D%2244%22%20height%3D%226%22%20rx%3D%221%22%20fill%3D%22%23312065%22%20opacity%3D%220.3%22%2F%3E%0A%20%20%20%20%20%20%3Crect%20x%3D%22-46%22%20y%3D%22-50%22%20width%3D%2292%22%20height%3D%2298%22%20rx%3D%226%22%20fill%3D%22url(%23reconBody)%22%20stroke%3D%22%23312065%22%20stroke-opacity%3D%220.45%22%20stroke-width%3D%221.5%22%2F%3E%0A%20%20%20%20%20%20%3Crect%20x%3D%22-40%22%20y%3D%22-32%22%20width%3D%2280%22%20height%3D%2262%22%20rx%3D%222%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.92%22%2F%3E%0A%20%20%20%20%20%20%3Crect%20x%3D%22-34%22%20y%3D%22-24%22%20width%3D%2258%22%20height%3D%222.8%22%20rx%3D%221.4%22%20fill%3D%22%235b21b6%22%20opacity%3D%220.6%22%2F%3E%0A%20%20%20%20%20%20%3Crect%20x%3D%22-34%22%20y%3D%22-17%22%20width%3D%2248%22%20height%3D%222%22%20rx%3D%221%22%20fill%3D%22%23312065%22%20opacity%3D%220.35%22%2F%3E%0A%20%20%20%20%20%20%3Crect%20x%3D%22-34%22%20y%3D%22-11%22%20width%3D%2264%22%20height%3D%222%22%20rx%3D%221%22%20fill%3D%22%23312065%22%20opacity%3D%220.25%22%2F%3E%0A%20%20%20%20%20%20%3Crect%20x%3D%22-34%22%20y%3D%22-5%22%20width%3D%2238%22%20height%3D%222%22%20rx%3D%221%22%20fill%3D%22%23312065%22%20opacity%3D%220.25%22%2F%3E%0A%20%20%20%20%20%20%3Cline%20x1%3D%22-46%22%20y1%3D%226%22%20x2%3D%22-46%22%20y2%3D%2244%22%20stroke%3D%22%23312065%22%20stroke-opacity%3D%220.5%22%2F%3E%0A%20%20%20%20%20%20%3Cline%20x1%3D%22-46%22%20y1%3D%2214%22%20x2%3D%22-42%22%20y2%3D%2214%22%20stroke%3D%22%23312065%22%20stroke-opacity%3D%220.5%22%2F%3E%0A%20%20%20%20%20%20%3Cline%20x1%3D%22-46%22%20y1%3D%2222%22%20x2%3D%22-42%22%20y2%3D%2222%22%20stroke%3D%22%23312065%22%20stroke-opacity%3D%220.5%22%2F%3E%0A%20%20%20%20%20%20%3Cline%20x1%3D%22-46%22%20y1%3D%2230%22%20x2%3D%22-42%22%20y2%3D%2230%22%20stroke%3D%22%23312065%22%20stroke-opacity%3D%220.5%22%2F%3E%0A%20%20%20%20%20%20%3Cline%20x1%3D%22-46%22%20y1%3D%2238%22%20x2%3D%22-42%22%20y2%3D%2238%22%20stroke%3D%22%23312065%22%20stroke-opacity%3D%220.5%22%2F%3E%0A%20%20%20%20%3C%2Fg%3E%3C%2Fg%3E%0A%3Ctext%20x%3D%22240%22%20y%3D%22334%22%20text-anchor%3D%22middle%22%20font-family%3D%22ui-sans-serif%2Csystem-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%22%20font-size%3D%2213%22%20font-weight%3D%22500%22%20fill%3D%22%23312065%22%20opacity%3D%220.85%22%3ECeleragesic%3C%2Ftext%3E%0A%3C%2Fsvg%3E)